Salt Lake City-based private equity firm Cimarron Healthcare Capital LP, which focuses on lower-middle-market healthcare investments, acquired Thousand Oaks, Calif.-based Infusion Management.
Financial terms of the majority recapitalization and growth equity capital raise were not made public.
The acquired company is the exclusive management services organization affiliated with Infusion for Health, which provides infusion therapy treatment for Greater Los Angeles area patients with multiple sclerosis, rheumatoid arthritis, and other autoimmune and immunodeficiency disorders.
Concurrently with the deal closing, Michael Tahery was named medical director of Infusion for Health.
